Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02910583 |
Title | Ibrutinib Plus Venetoclax in Patients With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma |
Acronym | Captivate |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Pharmacyclics LLC. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | POL | NZL | ITA | ESP | AUS |